PLUTAVIMAB
UNII 12U14K0SR5

Substance Identification & Data

This profile provides standardized clinical and technical data for Plutavimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 12U14K0SR5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2529854-88-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

12U14K0SR5

CAS Registry Number

2529854-88-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PLUTAVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C182098

National Cancer Institute reference terminology for clinical and research data.

INN ID

12159

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-186

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Plutavimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PLUTAVIMAB

Common Names & Synonyms

AFFINITY MATURED COVI-GUARD

IMMUNOGLOBULIN G1 (234-ALANINE,235-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL STI-2020 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL STI-2020 .KAPPA.-CHAIN, DIMER

PLUTAVIMAB [INN]

PLUTAVIMAB [USAN]

STI 2020 [WHO-DD]